Targeting triple‐negative breast cancer with an aptamer‐functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies

BACKGROUND: Areas of hypoxia are often found in triple-negative breast cancer (TNBC), it is thus more difficult to treat than other types of breast cancer, and may require combination therapies. A new strategy that combined bioreductive therapy with photodynamic therapy (PDT) was developed herein to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Yi-Te, Lin, Chih-Yu, Wen, Jyun-Wei, Hung, Ling-Chun, Chang, Ying-Feng, Yang, Chia-Min, Wu, Li-chen, Ho, Ja-an Annie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008604/
https://www.ncbi.nlm.nih.gov/pubmed/33781277
http://dx.doi.org/10.1186/s12951-021-00786-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008604/
https://www.ncbi.nlm.nih.gov/pubmed/33781277
http://dx.doi.org/10.1186/s12951-021-00786-8

Ejemplares similares